In this issue:
NOBEL: First-of-its-kind data on nivolumab + definitive CRT for OSCC
Comparable long-term survival with neoadjuvant or adjuvant CRT for OSCC
CLDN18.2 co-expression impacts efficacy of some front-line regimens
Does perioperative FLOT increase cure rates in oesophageal cancer?
Managing zolbetuximab GI toxicity is key to optimising outcomes
Sustained post-oesophagectomy decline in health-related quality of life
Pattern of LNM and recurrence in thoracic SCOC
Incidence and outcomes of solitary brain metastasis after oesophagectomy
CLDN18.2 positivity may diminish the efficacy of T-DXd
Cadonilimab vs PD-1 inhibitor-based therapy for low PD-L1 GEJ cancer
Please login below to download this issue (PDF)